NYSE · CIK 0000014272 · PHARMACEUTICAL PREPARATIONS
BRISTOL-MYERS SQUIBB COMPANY
BMY chart by TradingView
PRICE HISTORY
LIVE · NYSEBMY chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $48.2B
- EBITDA
- —
- FREE CASH FLOW
- $12.8B
- EPS
- $3.46
- GROSS MARGIN
- 71.08%
- ROIC
- 13.29%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
12.7x
-53%12.0x240.8x
⤢
P / SALES (TTM)
2.4x
-51%1.8x5.1x
⤢
P / BOOK
5.3x
-9%2.0x8.6x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
3.1x
-39%2.6x5.3x
⤢
FCF YIELD (TTM)
9.69%
+8.2pp1.51%16.64%
⤢
DIVIDEND YIELD (TTM)
4.36%
+1.5pp2.45%5.71%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$13.0B
+164%⤢
EBITDA (DERIVED)
—
⤢
NET INCOME
$3.3B
+176%⤢
EPS (DILUTED)
$1.62
+126%⤢
REVENUE GROWTH YOY
5.74%
-15.2pp-5.60%82.11%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
23.80%
+2.2pp6.59%54.66%
⤢
RETURN ON CAPITAL
16.44%
-1.5pp-16.15%51.36%
⤢
RETURN ON EQUITY (TTM)
41.59%
+20.0pp-54.78%41.59%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN71.28%
OPERATING MARGIN—
NET MARGIN25.57%
FCF MARGIN23.80%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$3.1B
+190%⤢
STOCK-BASED COMP
$0.1B
+181%⤢
CAPITAL EXPENDITURE
$0.3B
-11%⤢
SHARES OUTSTANDING
2.05B
+22%⤢
DIVIDEND / SHARE
$0.63
+66%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$8.7B
+154%⤢
TOTAL DEBT
$42.9B
+551%⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 84.79%INSIDERS 0.10%OTHER / RETAIL 15.11%3,262 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 8.40% | 171.7M | $11.11B | -2.9% |
| Vanguard Capital Management LLC | 6.48% | 132.3M | $8.56B | NEW |
| State Street Corporation | 4.83% | 98.6M | $6.38B | +0.6% |
| JPMORGAN CHASE & CO | 4.53% | 92.5M | $5.98B | +22.7% |
| Charles Schwab Investment Management, Inc. | 2.99% | 61.1M | $3.96B | -14.3% |
| Geode Capital Management, LLC | 2.71% | 55.3M | $3.58B | +5.0% |
| Vanguard Portfolio Management LLC | 2.26% | 46.2M | $2.99B | NEW |
| Bank of America Corporation | 1.60% | 32.6M | $2.11B | +116.4% |
| AQR Capital Management, LLC | 1.45% | 29.6M | $1.92B | +14.9% |
| Morgan Stanley | 1.43% | 29.2M | $1.89B | +3.0% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.